ARTRYA Ltd
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more
ARTRYA Ltd (AYA) - Net Assets
Latest net assets as of June 2025: AU$21.29 Million AUD
Based on the latest financial reports, ARTRYA Ltd (AYA) has net assets worth AU$21.29 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$23.68 Million) and total liabilities (AU$2.39 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$21.29 Million |
| % of Total Assets | 89.92% |
| Annual Growth Rate | 70.93% |
| 5-Year Change | -58.3% |
| 10-Year Change | N/A |
| Growth Volatility | 720.64 |
ARTRYA Ltd - Net Assets Trend (2019–2025)
This chart illustrates how ARTRYA Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ARTRYA Ltd (2019–2025)
The table below shows the annual net assets of ARTRYA Ltd from 2019 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$21.29 Million | +26.69% |
| 2024-06-30 | AU$16.80 Million | -45.01% |
| 2023-06-30 | AU$30.56 Million | -24.81% |
| 2022-06-30 | AU$40.64 Million | -20.39% |
| 2021-06-30 | AU$51.05 Million | +1947.78% |
| 2020-06-30 | AU$2.49 Million | +192.26% |
| 2019-06-30 | AU$852.97K | -- |
Equity Component Analysis
This analysis shows how different components contribute to ARTRYA Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 6413096200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$75.05 Million | 352.51% |
| Other Comprehensive Income | AU$10.52 Million | 49.42% |
| Total Equity | AU$21.29 Million | 100.00% |
ARTRYA Ltd Competitors by Market Cap
The table below lists competitors of ARTRYA Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AudioCodes Ltd
NASDAQ:AUDC
|
$148.38 Million |
|
Lanzhou Zhuangyuan Pasture Co Ltd
SHE:002910
|
$148.39 Million |
|
Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim A.S.
IS:AHGAZ
|
$148.40 Million |
|
Morris State Bancshares Inc
OTCQX:MBLU
|
$148.42 Million |
|
VIVO Cannabis Inc
PINK:ABCCF
|
$148.26 Million |
|
Albatron Technology Co Ltd
TWO:5386
|
$148.21 Million |
|
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SHE:002731
|
$148.12 Million |
|
Weihai Baihe Biology Technological Co. Ltd.
SHG:603102
|
$148.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ARTRYA Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 16,804,000 to 21,289,000, a change of 4,485,000 (26.7%).
- Net loss of 16,405,999 reduced equity.
- Share repurchases of 1,284,000 reduced equity.
- New share issuances of 20,070,000 increased equity.
- Other comprehensive income increased equity by 2,294,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-16.41 Million | -77.06% |
| Share Repurchases | AU$1.28 Million | -6.03% |
| Share Issuances | AU$20.07 Million | +94.27% |
| Other Comprehensive Income | AU$2.29 Million | +10.78% |
| Other Changes | AU$-189.00K | -0.89% |
| Total Change | AU$- | 26.69% |
Book Value vs Market Value Analysis
This analysis compares ARTRYA Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.36x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 282.06x to 13.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-06-30 | AU$0.01 | AU$3.08 | x |
| 2020-06-30 | AU$0.05 | AU$3.08 | x |
| 2021-06-30 | AU$1.48 | AU$3.08 | x |
| 2022-06-30 | AU$0.61 | AU$3.08 | x |
| 2023-06-30 | AU$0.39 | AU$3.08 | x |
| 2024-06-30 | AU$0.21 | AU$3.08 | x |
| 2025-06-30 | AU$0.23 | AU$3.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ARTRYA Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -77.06%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -58592.85%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.11x
- Recent ROE (-77.06%) is below the historical average (-45.49%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -17.08% | 0.00% | 0.00x | 1.07x | AU$-230.97K |
| 2020 | -54.31% | 0.00% | 0.00x | 1.07x | AU$-1.60 Million |
| 2021 | -7.99% | 0.00% | 0.00x | 1.02x | AU$-9.18 Million |
| 2022 | -42.21% | 0.00% | 0.00x | 1.08x | AU$-21.22 Million |
| 2023 | -36.44% | 0.00% | 0.00x | 1.08x | AU$-14.19 Million |
| 2024 | -83.31% | 0.00% | 0.00x | 1.13x | AU$-15.68 Million |
| 2025 | -77.06% | -58592.85% | 0.00x | 1.11x | AU$-18.53 Million |
Industry Comparison
This section compares ARTRYA Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $16,754,217
- Average return on equity (ROE) among peers: -53.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ARTRYA Ltd (AYA) | AU$21.29 Million | -17.08% | 0.11x | $148.36 Million |
| Adheris Health Limited (AHE) | $51.58 Million | 1.54% | 0.92x | $119.94 |
| Alcidion Group Ltd (ALC) | $6.57 Million | -38.71% | 0.23x | $60.88 Million |
| Blinklab Ltd (BB1) | $6.48 Million | -27.04% | 0.06x | $39.10 Million |
| Beamtree Holdings Ltd (BMT) | $29.22 Million | 1.31% | 0.10x | $18.03 Million |
| Cogstate Ltd (CGS) | $29.02 Million | 24.18% | 1.36x | $124.86 Million |
| Careteq Ltd (CTQ) | $3.55 Million | -121.85% | 1.13x | $621.63K |
| Doctor Care Anywhere Group Plc (DOC) | $12.29 Million | -179.31% | 0.79x | $21.76 Million |
| Echoiq Ltd (EIQ) | $6.77 Million | -79.92% | 0.22x | $168.60 Million |
| Emyria Ltd (EMD) | $5.31 Million | -59.24% | 0.25x | $11.75 Million |